First‐line therapies in late‐onset multiple sclerosis: An Italian registry study

BACKGROUND AND PURPOSE: The diagnosis of late‐onset (age ≥50 years old) relapsing remitting multiple sclerosis (LORRMS) has been increasingly described in clinical practice, whereas data focusing on the specific therapeutic management of LORRMS are scarce. Our objective was to compare the effectiven...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanghì, Aurora, Avolio, Carlo, Amato, Maria Pia, Filippi, Massimo, Trojano, Maria, Patti, Francesco, D’Amico, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291454/
https://www.ncbi.nlm.nih.gov/pubmed/34216532
http://dx.doi.org/10.1111/ene.15006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291454/
https://www.ncbi.nlm.nih.gov/pubmed/34216532
http://dx.doi.org/10.1111/ene.15006

Ejemplares similares